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Abstract
The nicotinic acetylcholine receptor (nAcChoR) has an absolute requirement for cholesterol if agonist-stimulated channel opening is to
occur [Biochemistry 25 (1986) 830]. Certain non-polar analogs could replace cholesterol in vectorial vesicle permeability assays. Using a
stopped-flow fluorescence assay to avoid the limitations of permeability assays imposed by vesicle morphology, it was shown that polar
conjugates of cholesterol could also satisfy the sterol requirement [Biochim. Biophys. Acta 1370 (1998) 299]. Here this assay is used to
explore the chemical specificity of sterols. Affinity-purified nAcChoRs from Torpedo were reconstituted into bilayers at mole ratios of
58:12:30 [1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC)/1,2-dioleoyl-sn-glycero-3-phosphate (DOPA)/steroid]. When the enantiomer of
cholesterol was used, or when the stereochemistry at the 3-hydroxy group was changed from h to a by substituting epicholesterol for
cholesterol, activation was still supported. The importance of cholesterol’s planar ring structure was tested by comparing planar cholestanol
(5a-cholestan-3h-ol) with nonplanar coprostanol (5h-cholestan-3h-ol). Both supported activation. Thus, these steroids support activation
independent of structural features known to be important for modulation of lipid bilayer properties. This provides indirect support for a
steroid binding site possessing very lax structural requirements.
D 2002 Elsevier Science B.V. All rights reserved.
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1. Introduction
The nicotinic acetylcholine receptor (nAcChoR) is a
ligand-gated postsynaptic ion channel whose function is
modulated by lipids. Besides a requirement for a fluid
phospholipid bilayer phase, agonist-induced ion flux is well
known to have an obligatory, although low-specificity
requirement for cholesterol [1–8]. In ion-flux assays, the
response depends on the morphology of the vesicles and
membrane leakiness, but a morphology-independent non-
vectorial fluorescence assay has confirmed the cholesterol
requirement [9]. Upon rapid mixing of receptors with
agonist and the reporter molecule ethidium bromide, the
earliest fluorescent component reported the fraction of
channels that opened and their apparent rate of fast desensi-
tization. Cholesterol was shown to modulate the channel
opening probability from zero in the absence of cholesterol,
to native values in the presence of >20 mol% cholesterol
[9]. The rate of fast desensitization remained unperturbed.
Upon establishing the threshold of required cholesterol, we
further probed the role of cholesterol in channel activation
by restricting the location of cholesterol in the bilayer by
covalently attaching polar moieties to its 3-hydroxy group
[10]. These conjugates were fully active and the functionally
important cholesterol sites appeared to be located close to
the lipid–protein interface.
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Here we expand the above studies to probe the structural
features of cholesterol that are required for channel activa-
tion. Specifically, we test the hypothesis that cholesterol’s
mechanism for support of activation is related to its well-
known abilities to modulate lipid fluidity [11–13]. We used
nAcChoRs from Torpedo that were affinity purified and
reconstituted into bilayers containing different cholesterol
analogs. We modulated the stereochemistry and the ring
structure. The structures of the main cholesterol analogs
used are shown in Fig. 1.
2. Materials and methods
2.1. Materials
Torpedo nobiliana were obtained live from Biofish Asso-
ciates (Georgetown, MA). Phospholipids and other materials
were obtained commercially as previously described [9,10].
Steroids were obtained from Steraloids, Inc., Newport, RI,
except for the enantiomer of natural cholesterol (ent-choles-
terol) which was a kind gift from Dr. Scott R. Rychnovsky,
UC, Irvine.
2.2. Purification and reconstitution of the nAcChoR using
affinity chromatography
Crude nAcChoR-rich membranes were prepared from
T. nobiliana and reconstituted into 1,2-dioleoyl-sn-glyc-
ero-3-phosphocholine (DOPC) lipid vesicles via detergent
dialysis as described [9]. They were kept at  80 jC
until needed. Re-reconstitution (lipid exchange) was per-
formed by solubilizing 3 mg (1 ml) of these nAcChoR/
DOPC membranes in 1 ml of buffer containing 2%
cholate (1% final concentration) and 2 mg of the desired
lipid mixture, with the lipid usually in the mole ratio of
58:12:30 DOPC/1,2-dioleoyl-sn-glycero-3-phosphate
(DOPA)/steroid. The solubilized mixture was then dia-
lyzed. The amount of steroid in the lipids of the affinity-
purified nAcChoR membranes was generally set at 30
mol% because receptor activation is maximal above 20–
25% cholesterol [9].
2.3. Characterization of reconstituted nAcChoR
Protein, phospholipid and cholesterol were determined
as previously described [9,10]. All bilayer compositions
are given in mole percentage. SDS-PAGE was performed
to verify the identity and purity of the receptor, and two
methods were used to determine the concentration of
agonist binding sites [9]. First, by competition of the
fluorescent cholinergic ligand, (dansylaminoethyl) trime-
thylammonium perchlorate, by acetylcholine and second
by [3H]AcCho binding. Receptor concentration refers to
protein unless agonist sites are specified which would be
two agonist sites per oligomer.
2.4. Determination of cholesterol and cholesterol deriva-
tives
Semiquantitative determination of cholesterol and choles-
terol analogs in reconstituted and re-reconstituted membrane
preparations was achieved by extraction and thin-layer chro-
matography (TLC) identification [10].
2.5. Stopped-flow fluorescence energy transfer assay
The stopped-flow fluorescence energy transfer experi-
ments were performed with a BioSX-17 MV spectro-
fluorimeter with a 150-W xenon arc lamp and a
SpectraKinetic monochromator fitted with a diffraction
grating (Applied Photophysics, Leatherhead, England).
All experiments were carried out at 20 jC in Torpedo
physiologic saline buffer (250 mM NaCl, 5 mM KCl, 3
mM CaCl2 2 mM MgCl2, 5 mM NaH2PO4, and 0.02%
NaN3 at pH 7.0.) Equal volumes of ethidium (plus ligands
where appropriate) and nAcChoR vesicle suspension were
rapidly mixed to give a final receptor concentration of 0.2
AM, equivalent to 0.4 AM in acetylcholine binding sites,
and 0.8 AM ethidium. When a high agonist concentration
was used, 10 mM carbamylcholine was always the final
concentration. Intrinsic tryptophan residues were excited at
290 nm (0.5 mm slit) causing resonance energy transfer to
the extrinsic probe ethidium bromide. Fluorescence was
recorded with a 530-nm-high band-pass cutoff filter. The
electronic filter was set to 150 As. Four to eight traces
were acquired digitally for each set of conditions and then
Fig. 1. The structures of some cholesterol analogs used in this study. (A)
Cholesterol; (B) epicholesterol; (C) cholestanol; and (D) coprostanol.
G.H. Addona et al. / Biochimica et Biophysica Acta 1609 (2003) 177–182178
signal averaged. Each trace (2000 data points) was
acquired for 100 s with the instrument in a logarithmic
timebase mode, and traces were fitted to two exponentials
corresponding to the early and fast components of refer-
ence [9]. This method was developed based on pioneering
work by a number of groups as detailed in our earlier
manuscripts [9,10].
3. Results
3.1. Characterization of the nAcChoR
Total lipid-to-protein mole ratios in all samples were
f 300:1. Aliquots of all samples containing cholesterol,
epicholesterol, cholestanol and coprostanol were extracted
from the re-reconstituted membranes and analyzed by TLC
with every sample showing expected quantities of steroid
(30%). Most importantly, no traces of residual cholesterol
from native membrane preparations were observed in the
stock nAcChoR reconstituted into DOPC.
3.2. Effects of cholesterol stereoisomers on nAcChoR
activation
Fig. 2 shows the time dependence of ethidium fluores-
cence after rapid mixing of re-reconstituted nAcChoR mem-
branes containing 30 mol% cholesterol and a solution of
ethidium and carbamylcholine yielding a final concentration
of 0.8 AM ethidium and 10 mM carbamylcholine. An early
component, reporting the fraction of channels that opened
and their apparent rate of fast desensitization (see Introduc-
tion), is observed within the first second in the presence but
not the absence (not shown here) of 10 mM carbamylcholine
[9,10]. The early component had a rate of 4.7F 0.54 s 1 that
is consistent with steroids that support activation induced by
10 mM carbamylcholine. This and all early component rates
below fell within the range previously reported for choles-
terol [9]. The early component was not observed in the
presence of 10 mM carbamylcholine for nAcChoR reconsti-
tuted into DOPC/DOPA (lower trace Fig. 2).
When nAcChoR membranes were reconstituted with 30
mol% ent-cholesterol, in which every chiral center in choles-
Fig. 2. The effect of agonist (carbachol) on the time-resolved fluorescence
of ethidium rapidly mixed with nAcChoR reconstituted into membranes
with various lipid compositions. The final concentrations of ethidium,
reconstituted nAcChoR and carbachol were 0.8 AM, 0.2 AM and 10 mM,
respectively, in each trace. The lower traces are nAcChoR reconstituted into
DOPC/DOPA at a mole ratio of 88:12. The upper traces are nAcChoR re-
reconstituted into membranes containing in addition 30 mol% cholesterol at
a mole ratio of 58:12:30 DOPC/DOPA/cholesterol.
Fig. 3. The effect of cholesterol analogs on state transitions of the nAcChoR (0.2 AM) induced by 10 mM carbachol and detected using 0.8 AM ethidium. In
each panel, the lower trace has no carbachol and the upper trace has 10 mM carbachol. An early phase was observed for each steroid, but only in the presence
of carbachol (see Results). The mole ratio of steroid was always 30%, to give a composition of 58:12:30 DOPC/DOPA/sterol. (A) Ent-cholesterol; (B)
epicholesterol; (C) coprostanol; and (D) cholestanol.
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terol is reversed [14], the agonist-dependent early component
was observed with a rate of 1.3F 0.043 s 1 (Fig. 3A).
To examine the role of the 3-hydroxyl group, nAcChoR
membranes were reconstituted with 30 mol% epicholesterol,
the 3a-enantiomer of cholesterol. Fig. 3B shows the time
dependence of ethidium fluorescence following rapid mix-
ing of carbamylcholine plus ethidium with the epicholes-
terol-containing receptor membranes. With no agonist
present, no early component was observed but at 10 mM
carbachol, there was an early component with a rate of
3.9F 0.49 s 1. Thus, 30 mol% epicholesterol supports
rapid agonist-induced conformational changes.
3.3. Modulation of the ring structure
When the 5–6 double bond is reduced, the effect on the
steroid ring geometry depends on whether the hydrogen on
carbon 5 is cis (coprostanol) or trans (cholestanol) to the
methyl on carbon 10 (Fig. 1). When the nAcChoR was
reconstituted with 30 mol% of either of these two steroids,
an agonist-induced early component was observed. With
coprostanol and cholestanol, the early components had rates
of 2.04F 0.067 and 3.8F 0.42 s 1, respectively (Fig. 3C
and D).
4. Discussion
Previously we have characterized the early phase of
agonist-induced action on ethidium fluorescence to be
associated with gating [9,10]. Such gating depended on
the presence of cholesterol, and cholesterol tethered to
lysophosphatidylcholine via a 2-succinyl spacer [oleoyl-2-
(cholesteryl hemisuccinyl)phosphatidylcholine (tethered-
cholesterol) [15]] also supported gating. This suggested
that if any cholesterol sites were involved, they would be
close to the lipid–protein interface (periannular sites [10])
rather than deep within the protein (interstitial sites [16]).
Although some studies rule out a role for lipid fluidity
[4,15], others suggest the importance of sterols for stabi-
lizing resting states of the nAcChoR [8]. Indeed, previous
studies do not rule out a role in gating for annular lipid
(that lipid which is nearest neighbor to the nAcChoR). Our
present study compares the ability of a structurally diverse
set of steroids to support nAcChoR activation (Fig. 3) with
their known effects on lipid bilayer structure and function
[17–20]). Our results are best appreciated by considering
two important structural features of the steroids employed
and how they influence lipid bilayers (Fig. 1).
First, only when the hydroxy group at the 3-position on
ring A is in the equatorial h position do steroids order
bilayers, increase monolayer packing and decrease bilayer
permeability [17,18,21]. Switching the hydroxy group from
the h to the a position (cholesterol to epicholesterol) ablates
these actions, yet it did not alter the ability to support gating
of the nAcChoR (Fig. 2 vs. Fig. 3B).
Secondly, a planar steroid ring system is critical for the
above mentioned sterol actions on lipid bilayers [18,19].
Cholesterol has a tetracyclic ring structure, consisting of
three six-membered rings, classically labeled from the left
(Fig. 1) as A, B and C, and one five-membered ring labeled
D. The B–C and C–D ring fusion occurs at single bonds
whose substituents are trans, allowing the ring system to
adopt a planar conformation. These structural features are
thought to have been optimized during biochemical evolu-
tion [11]. In cholesterol, the presence of the unsaturated
double bond at the AB ring junction prevents the A- and B-
rings from adopting full chair conformations.
Cholestanol and coprostanol are reduced derivatives of
cholesterol with the 5–6 double bond saturated. In choles-
tanol, the 5-hydrogen is trans to the 10-methyl group,
allowing the A and B cyclohexyl rings to adopt coplanar
chair conformations. In coprostanol, on the other hand, the
5-hydrogen is cis to the 10-methyl, twisting the A ring
system out of the plan of the steroid backbone (Fig. 1) and
removing its ability to exert cholesterol-like actions on lipid
properties. Reduction of the 5–6 double bond without
disruption of the planar ring system (cholesterol to choles-
tanol) caused no change in the ability to support gating. In
spite of the dramatic difference in ring structure between
cholestanol and coprostanol, the ability of carbachol to
cause gating remained intact (Fig. 3D vs. C).
Thus, two important determinants of the sterol structure
that are well known to optimize phospholipid–sterol inter-
actions in lipid bilayers do not influence the ability of the
nAcChoR to gate. Although, annular lipid packing in the
lipid–protein interface might be significantly different from
that in bilayers, the gross structural difference between
cholestanol and coprostanol makes this unlikely. Thus, lipid
bilayer physical properties may not be the key factor in
permitting agonist-induced nAcChoR activation, although
they may be in slow conformational changes such as
desensitization [7,8]. Our data confirm the nonspecificity
observed previously in vectorial nAcChoR-assay systems
[1,3,4], and they extend the lack of specificity previously
observed with the present fluorescence assay with regard to
3-h esters. For example, cholesterol 3-phosphocholine,
cholesterol 3-sulfate and tethered-cholesterol all supported
agonist-induced activation [10].
Cholesterol has several chiral carbons and the mirror
image of natural cholesterol (nat-cholesterol), ent-choles-
terol, has been synthesized [14,22]. The physical properties
of ent-cholesterol and nat-cholesterol are therefore identical
unless they are interacting with a chiral target to form
diastereomeric complexes. Ent-cholesterol does not interact
diastereomerically with phospholipids including DOPC
[23]. However, it does not support life in the nematode
Caenorhabditis elegans, which requires exogenous sterols
for viability [22], and in cholesterol–amphotericin B com-
plexes, ent-cholesterol interacts with lower affinity but
forms channels of higher conductance than nat-cholesterol,
providing a clear example of diastereomeric interactions
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distinguishing between nonspecific and specific models of
action [24]. We found that ent-cholesterol supported ago-
nist-induced gating in the nAcChoR, providing no evidence
in favor of enantiospecific interactions with the nAcChoR
and confirming that the stereochemistry of the 3-h position
is unimportant.
Even compared to other sterol-requiring receptors, the
lax structural specificity of the nAcChoR is unique. Thus, in
a recent review of the role of cholesterol as an obligatory
activator of receptor proteins, two G-protein-coupled recep-
tors with seven putative membrane-spanning domains were
considered, namely, the oxytocin and the cholecystokinin
receptors [25]. Cholesterol analogs were added as cyclo-
dextrin complexes to cholesterol-depleted receptor mem-
branes. Both receptors could be reactivated with cholesterol,
coprostanol and certain other modified sterols, but the
oxytocin receptor was much more specific in its sterol
activator requirement. Thus, the cholecystokinin receptor,
but not the oxytocin receptor, could be reactivated with
epicholesterol or 3-keto-cholesterol. It was concluded that
activation of the cholecystokinin but not the oxytocin
receptor was related to lipid fluidity [25].
Previous work has suggested that there might be choles-
terol binding sites on the nAcChoR [10,16]. Although the
structure of the nAcChoR’s transmembrane domains is as
yet unknown [26], certain inferences can be drawn about
these sites. They are thought to be located near the lipid–
protein interface, possibly in the receptor’s interior (inter-
stitial sites [16]) but with the polar end of the site within 6 A˚
of the lipid bilayer (periannular sites [10]). Furthermore,
large substituents are tolerated on the 3 position of the steroid
ring [10], and neither the 3-h hydroxyl nor the planarity of
the steroid ring system now seems to be required.
In conclusion, our results are in agreement with previous
work that the effect of cholesterol on the physical properties
of the lipid bilayer is not the primary determinant of the
action of steroids in permitting agonist-induced nAcChoR
activation.
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